Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy in locoregionally advanced head and neck cancer

被引：0
作者：
Seol, Y. [1 ]
Jin, C. Y. J. Choi Yong [1 ]
机构：
[1] Pusan Natl Univ Hosp, Pusan, South Korea
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3234
引用
收藏
页码：S769 / S769
页数：1
相关论文
共 50 条
  • [31] The use of concurrent chemotherapy and radiotherapy for locoregionally advanced head and neck cancer
    Vokes, EE
    Haraf, DJ
    Kies, MS
    SEMINARS IN ONCOLOGY, 2000, 27 (04) : 34 - 38
  • [32] Toxicity and one-year tumor control with induction chemotherapy and bioradiotherapy for locally advanced unresectable head and neck cancer
    Mercke, C.
    Haugen, H.
    Adell, G.
    Costa-Svedman, F.
    Nyman, J.
    Wickart-Johansson, G.
    Sjodin, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [33] Does induction chemotherapy have a role in the management of locoregionally advanced squamous cell head and neck cancer?
    Adelstein, David J.
    LeBlanc, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (17) : 2624 - 2628
  • [34] Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial
    Haddad, Robert
    O'Neill, Anne
    Rabinowits, Guilherme
    Tishler, Roy
    Khuri, Fadlo
    Adkins, Douglas
    Clark, Joseph
    Sarlis, Nicholas
    Lorch, Jochen
    Beitler, Jonathan J.
    Limaye, Sewanti
    Riley, Sarah
    Posner, Marshall
    LANCET ONCOLOGY, 2013, 14 (03) : 257 - 264
  • [35] Induction chemotherapy (IC) and concomitant chemoradiotherapy (CCRT) for locally advanced head and neck cancer (LAHNC).
    Ferrari, D
    Jerekzec-Fossa, B
    Chiesa, F
    Rocca, A
    Ansarin, M
    Oldani, S
    Tartaro, T
    Bruschini, R
    Orecchia, R
    Foa, P
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 524S - 524S
  • [36] Phase II study of induction chemotherapy followed by concomitant chemoradiotherapy in advanced head and neck cancer:: Clinical response and organ/function preservation
    Mantovani, G
    Macciò, A
    Massa, E
    Mulas, C
    Mudu, MC
    Massidda, S
    Massa, D
    Murgia, V
    Ferreli, L
    Succu, G
    Astara, G
    Proto, E
    Tore, G
    Mura, M
    Maxia, G
    ONCOLOGY REPORTS, 1999, 6 (06) : 1425 - 1430
  • [37] The Clinical Outcomes and Toxicities of Induction Chemotherapy Followed by Concurrent Chemoradiotherapy Plus Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
    Zou, Rui
    Yuan, Jing-Jing
    Li, Qiang
    Ding, Jian-Wu
    Liao, Bing
    Tu, Zi-Wei
    Hu, Rong-Huan
    Gong, Dan
    Hu, Jia-Li
    Zeng, Lei
    FRONTIERS IN ONCOLOGY, 2021, 10
  • [38] Therapy for locoregionally advanced head and neck cancer
    Vokes, EE
    SEMINARS IN RADIATION ONCOLOGY, 1997, 7 (03) : 4 - 7
  • [39] Phase II study of docetaxel, cisplatin, and 5-FU induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal cancer
    Woo Kyun Bae
    Jun Eul Hwang
    Hyun Jeong Shim
    Sang Hee Cho
    Joon Kyoo Lee
    Sang-Chul Lim
    Woong-Ki Chung
    Ik-Joo Chung
    Cancer Chemotherapy and Pharmacology, 2010, 65 : 589 - 595
  • [40] Phase II study of docetaxel, cisplatin, and 5-FU induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal cancer
    Bae, Woo Kyun
    Hwang, Jun Eul
    Shim, Hyun Jeong
    Cho, Sang Hee
    Lee, Joon Kyoo
    Lim, Sang-Chul
    Chung, Woong-Ki
    Chung, Ik-Joo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 65 (03) : 589 - 595
12345